Publications by authors named "Ken-ichi Inui"

Claim this Profile
N
Novel drug transporter substrates identification: An innovative approach based on metabolomic profiling, in silico ligand screening and biological validation.
Anne T Nies, Jörg König, Patrick Leuthold, Katja Damme, Stefan Winter, Ken-Ichi Inui

Pharmacol Res· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Concise Guide to PHARMACOLOGY 2023/24: Transporters.
Stephen P H Alexander, Doriano Fabbro, Eamonn Kelly, Alistair A Mathie, John A Peters, Ken-Ichi Inui

Br J Pharmacol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Transporters.
Stephen Ph Alexander, Eamonn Kelly, Alistair Mathie, John A Peters, Emma L Veale, Ken-Ichi Inui

Br J Pharmacol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibitory effects of vandetanib on creatinine transport via renal organic cation transporter OCT2.
Yuko Tanihara, Satohiro Masuda, Ken-Ichi Inui

Eur J Pharm Sci· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of vitamin K2 on the anticoagulant activity of warfarin during the perioperative period of catheter ablation: Population analysis of retrospective clinical data.
Zhi Zhou, Ikuko Yano, Sumiko Odaka, Yosuke Morita, Satoshi Shizuta, Ken-Ichi Inui

J Pharm Health Care Sci· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disruption of Slc52a3 gene causes neonatal lethality with riboflavin deficiency in mice.
Hiroki Yoshimatsu, Atsushi Yonezawa, Kaori Yamanishi, Yoshiaki Yao, Kumiko Sugano, Ken-Ichi Inui

Sci Rep· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Telaprevir-Induced Renal Adverse Events in Japanese Patients Reported in the PMDA Adverse Drug Reactions Reporting Database.
Ayami Ichida, Hideyuki Motohashi, Asuka Kitano, Akira Takayama, Ken-Ichi Inui

Ther Innov Regul Sci· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of dose variability and side effects for individualized cancer pharmacotherapy with tyrosine kinase inhibitors.
Tomohiro Terada, Satoshi Noda, Ken-Ichi Inui

Pharmacol Ther· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of decreased mRNA expression of multidrug and toxin extrusion protein 1 in peripheral blood cells with the development of flutamide-induced liver injury.
Kazuhiko Nakano, Hitoshi Ando, Shinsuke Kurokawa, Keiko Hosohata, Kentarou Ushijima, Ken-Ichi Inui

Cancer Chemother Pharmacol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the potency of telaprevir and its metabolites as inhibitors of renal organic cation transporters, a potential mechanism for the elevation of serum creatinine.
Tomohisa Nakada, Tomoko Kito, Katsuhisa Inoue, Satohiro Masuda, Ken-ichi Inui

Drug Metab Pharmacokinet· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Valacyclovir-Induced Acute Kidney Injury in Japanese Patients Based on the PMDA Adverse Drug Reactions Reporting Database.
Asuka Kitano, Hideyuki Motohashi, Akira Takayama, Ken-Ichi Inui, Yoshitaka Yano

Ther Innov Regul Sci· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between CYP3A5 genotypes in graft liver and increase in tacrolimus biotransformation from steroid treatment in living-donor liver transplant patients.
Keiko Hosohata, Miwa Uesugi, Sachiyo Hashi, Mio Hosokawa, Ken-Ichi Inui

Drug Metab Pharmacokinet· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of ABCG2 genotype on the population pharmacokinetics of sunitinib in patients with renal cell carcinoma.
Tomoyuki Mizuno, Masahide Fukudo, Tsuyoshi Fukuda, Tomohiro Terada, Min Dong, Ken-Ichi Inui

Ther Drug Monit· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developmental trajectory of intestinal MDR1/ABCB1 mRNA expression in children.
Tomoyuki Mizuno, Tsuyoshi Fukuda, Satohiro Masuda, Shinji Uemoto, Kazuo Matsubara, Ken-Ichi Inui

Br J Clin Pharmacol· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigation of endogenous compounds for assessing the drug interactions in the urinary excretion involving multidrug and toxin extrusion proteins.
Koji Kato, Haruyuki Mori, Tomoko Kito, Miyu Yokochi, Sumito Ito, Ken-ichi Inui

Pharm Res· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Renal tubular secretion of varenicline by multidrug and toxin extrusion (MATE) transporters.
Moto Kajiwara, Satohiro Masuda, Shingo Watanabe, Tomohiro Terada, Toshiya Katsura, Ken-ichi Inui

Drug Metab Pharmacokinet· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of genetic variation in breast cancer resistance protein (BCRP/ABCG2) on sunitinib pharmacokinetics.
Tomoyuki Mizuno, Masahide Fukudo, Tomohiro Terada, Tomomi Kamba, Eijiro Nakamura, Ken-Ichi Inui

Drug Metab Pharmacokinet· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multidrug and toxin extrusion family SLC47: physiological, pharmacokinetic and toxicokinetic importance of MATE1 and MATE2-K.
Hideyuki Motohashi, Ken-ichi Inui

Mol Aspects Med· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel riboflavin transporter family RFVT/SLC52: identification, nomenclature, functional characterization and genetic diseases of RFVT/SLC52.
Atsushi Yonezawa, Ken-ichi Inui

Mol Aspects Med· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Precise comparison of protein localization among OCT, OAT, and MATE in human kidney.
Hideyuki Motohashi, Yumi Nakao, Satohiro Masuda, Toshiya Katsura, Tomomi Kamba, Ken-Ichi Inui

J Pharm Sci· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics/pharmacodynamics of erlotinib and pharmacogenomic analysis of plasma and cerebrospinal fluid drug concentrations in Japanese patients with non-small cell lung cancer.
Masahide Fukudo, Yasuaki Ikemi, Yosuke Togashi, Katsuhiro Masago, Young Hak Kim, Ken-Ichi Inui

Clin Pharmacokinet· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent advances in structural biology of peptide transporters.
Tomohiro Terada, Ken-ichi Inui

Curr Top Membr· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Organic cation transporter OCTs (SLC22) and MATEs (SLC47) in the human kidney.
Hideyuki Motohashi, Ken-ichi Inui

AAPS J· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Urinary chemokine (C-C motif) ligand 2 (monocyte chemotactic protein-1) as a tubular injury marker for early detection of cisplatin-induced nephrotoxicity.
Kumiko Nishihara, Satohiro Masuda, Haruka Shinke, Aiko Ozawa, Takaharu Ichimura, Ken-Ichi Inui

Biochem Pharmacol· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Involvement of autophagy in the pharmacological effects of the mTOR inhibitor everolimus in acute kidney injury.
Shunsaku Nakagawa, Kumiko Nishihara, Ken-ichi Inui, Satohiro Masuda

Eur J Pharmacol· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis